BRKR Bruker Corporation

Bruker Daltonics Inc. today announces that Sebastian Meyer-Plath has been appointed as the Company's Vice President for its Nuclear, Biological and Chemical (NBC) detection business, effective immediately. Mr. Meyer-Plath will be responsible for Bruker Daltonics' global NBC detection business including strategy, marketing and sales management, its world-wide distribution organization, as well as other aspects of the NBC detection business. He will also be a managing director (Geschaeftsfuehrer) of Bruker Daltonik GmbH with management responsibility for the Bruker Daltonik operation in Leipzig, Germany. Mr. Meyer-Plath had originally joined Bruker in 1993, and held several project and product management positions, both in NBC detection and the life-science systems business. In 2002, he joined life science start-up business Advalytix AG in Germany. A year later, Mr. Meyer-Plath joined Smiths Detection as Vice President of Sales & Marketing for UK and international defense markets, based in the U.K. He holds a degree in biology from the University of Bonn. Sebastian Meyer-Plath said: "I am very pleased to have the opportunity to further expand Bruker Daltonics' established NBC detection market capabilities. Based on Bruker Daltonics' impressive and broad technology base, it is well positioned to meet the rapidly evolving requirements of the international NBC/CBRN detection community." Frank Laukien, President and CEO of Bruker BioSciences, commented: "I am very pleased to have Sebastian rejoin Bruker Daltonics. He had an excellent track record at Bruker Daltonics and has gained significant additional management and marketing experience in his recent positions. I am sure that he will make a substantial positive contribution to our NBC detection business as well as to our corporate goals." ABOUT BRUKER BIOSCIENCES (NASDAQ: BRKR) Bruker BioSciences Corporation, headquartered in Billerica, Massachusetts, is the publicly traded parent company of Bruker AXS Inc. and Bruker Daltonics Inc. Bruker AXS is a leading developer and provider of life science and advanced materials research tools based on X-ray technology. Bruker Daltonics is a leading developer and provider of innovative life science tools based on mass spectrometry. Bruker Daltonics also offers a broad line of nuclear, biological and chemical (NBC) detection products for defense and homeland security. For more information, please visit www.bruker-biosciences.com CAUTIONARY STATEMENT Any statements contained in this press release that do not describe historical facts may constitute forward-looking statements as that term is defined in the Private Securities Litigation Reform Act of 1995. Any forward-looking statements contained herein are based on current expectations, but are subject to a number of risks and uncertainties. The factors that could cause actual future results to differ materially from current expectations include, but are not limited to, risks and uncertainties relating to the Company's reorganization strategies, integration risks, failure of conditions, technological approaches, product development, market acceptance, cost and pricing of the Company's products, changes in governmental regulations, capital spending and government funding policies, FDA and other regulatory approvals to the extent applicable, competition, the intellectual property of others, patent protection and litigation. These and other factors are identified and described in more detail in our filings with the SEC, including, without limitation, our respective annual reports on Form 10-K for the year ended December 31, 2004, our most recent quarterly reports on Form 10-Q, our current reports on Form 8-K and the joint proxy statement/prospectus filed in connection with the merger. We disclaim any intent or obligation to update these forward-looking statements.